Chardan Capital Weighs in on uniQure FY2025 Earnings
uniQure (NASDAQ:QURE – Free Report) – Stock analysts at Chardan Capital issued their FY2025 earnings estimates for uniQure in a research note issued to investors on Tuesday, April 1st. Chardan Capital analyst Y. Livshits expects that the biotechnology company will earn ($3.90) per share for the year. Chardan Capital currently has a “Buy” rating and […]
uniQure (NASDAQ:QURE – Free Report) – Stock analysts at Chardan Capital issued their FY2025 earnings estimates for uniQure in a research note issued to investors on Tuesday, April 1st. Chardan Capital analyst Y. Livshits expects that the biotechnology company will earn ($3.90) per share for the year. Chardan Capital currently has a “Buy” rating and […]